Effect of After-Treatment of Strychnos ligustrina Extract on The Percentage of Parasitemia in Mice Infected with Plasmodium berghei

Umi Cahyaningsih; Siti Sa’diah; Wasrin Syafii; Rita K. Sari; Harisyah M; Maeda Wahyuningrum

doi:10.1051/e3sconf/202015101023

All issues

Volume 151 (2020)

E3S Web Conf., 151 (2020) 01023

References

Open Access

Issue		E3S Web Conf. Volume 151, 2020 The 1^st International Conference on Veterinary, Animal, and Environmental Sciences (ICVAES 2019)


Article Number		01023
Number of page(s)		3
DOI		https://doi.org/10.1051/e3sconf/202015101023
Published online		14 February 2020

Taylor MA, Coop RL, Wall RL. Veterinary Parasitology Third Edition. Oxford (UK): Blackwell Publishing. 2007. [Google Scholar]
Raini M. Gitawati R. Isnawati A, et al.: Keluhan dan Kepatuhan Penderita malaria Terhadap Pengobatan Malaria Artesunat-Amodiakuin di kalimantan dan Sulawesi. Media Penelitian dan Pengembangan Kesehatan. 2011; 21(3): 111–118. [Google Scholar]
Noedl H. Socheat D. Satimai W. Artemisinin-Resistant malaria in Asia. N Engl J, 2009; 361(5): 540–541. [CrossRef] [Google Scholar]
Frederich M. Hayette MP. Tits M, et al.: In vitro activities of Strychnos alkaloids and extract against Plasmodium falciparum. Antimicrob. Agents Chemother. 1999; 43(9): 2328–2331. [CrossRef] [Google Scholar]
Syafii W. Sari RK. Cahyaningsih U, et al.: Antimalarial Activity of Bidara laut Wood Extract. Jurnal Ilmu Teknologi kayu Tropis. 2016; 14(1): 1–10. [Google Scholar]
Basir R. Fazalul Rahiman SS. Hasballah K. et al.: Plasmodium berghei. ANKA infection in ICR mice as a model of cerebral malaria. Iran J Parasitol. 2012; 7(4): 62–74. [Google Scholar]
Yusuf Y. Faktor resiko munculnya Plasmodium spp resisten di Kecamatan Tapalang, Sulawesi Barat. Jurnal Bionature. 2014; 15(1): 41–44. [Google Scholar]
Hasugian AR. Risniati Y. Tjitra E. et al.: Efikasi dan Keamanan Dihidroartemisinin Piperakuin Pada Penderita Plasmodium vivax di Kalimantan dan Sulawesi. Media Litbang Kesehatan. 2012; 22(2): 78–86. [Google Scholar]
Azlin E. Obat anti malaria. Sari Pediatri. 2004;5(4): 150–154. [CrossRef] [Google Scholar]
Layal K. Gayatri A. Pengaruh CYP2D6 terhadap Kegagalan Terapi Primakuin pada Malaria Vivaks. Syifa Medika. 2014; 4(1): 1–15. [Google Scholar]
Daher A. Yulio C. Silva L. et al.: Evaluation of P.vivax malaria recurrence in Brazil. Malar J. 2019;18:18. [CrossRef] [PubMed] [Google Scholar]
Brasil LW. Soares FR. Santoro AB. et al.: CYP2D6 activity and risk of recurrence of P. vivax malaria in Brazilian Amazon: a prospective cohort study. Malar J. 2018;17:57. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.

[1] Taylor MA, Coop RL, Wall RL. Veterinary Parasitology Third Edition. Oxford (UK): Blackwell Publishing. 2007. [Google Scholar]

[2] Raini M. Gitawati R. Isnawati A, et al.: Keluhan dan Kepatuhan Penderita malaria Terhadap Pengobatan Malaria Artesunat-Amodiakuin di kalimantan dan Sulawesi. Media Penelitian dan Pengembangan Kesehatan. 2011; 21(3): 111–118. [Google Scholar]

[3] Noedl H. Socheat D. Satimai W. Artemisinin-Resistant malaria in Asia. N Engl J, 2009; 361(5): 540–541. [CrossRef] [Google Scholar]

[4] Frederich M. Hayette MP. Tits M, et al.: In vitro activities of Strychnos alkaloids and extract against Plasmodium falciparum. Antimicrob. Agents Chemother. 1999; 43(9): 2328–2331. [CrossRef] [Google Scholar]

[5] Syafii W. Sari RK. Cahyaningsih U, et al.: Antimalarial Activity of Bidara laut Wood Extract. Jurnal Ilmu Teknologi kayu Tropis. 2016; 14(1): 1–10. [Google Scholar]

[6] Basir R. Fazalul Rahiman SS. Hasballah K. et al.: Plasmodium berghei. ANKA infection in ICR mice as a model of cerebral malaria. Iran J Parasitol. 2012; 7(4): 62–74. [Google Scholar]

[7] Yusuf Y. Faktor resiko munculnya Plasmodium spp resisten di Kecamatan Tapalang, Sulawesi Barat. Jurnal Bionature. 2014; 15(1): 41–44. [Google Scholar]

[8] Hasugian AR. Risniati Y. Tjitra E. et al.: Efikasi dan Keamanan Dihidroartemisinin Piperakuin Pada Penderita Plasmodium vivax di Kalimantan dan Sulawesi. Media Litbang Kesehatan. 2012; 22(2): 78–86. [Google Scholar]

[9] Azlin E. Obat anti malaria. Sari Pediatri. 2004;5(4): 150–154. [CrossRef] [Google Scholar]

[10] Layal K. Gayatri A. Pengaruh CYP2D6 terhadap Kegagalan Terapi Primakuin pada Malaria Vivaks. Syifa Medika. 2014; 4(1): 1–15. [Google Scholar]

[11] Daher A. Yulio C. Silva L. et al.: Evaluation of P.vivax malaria recurrence in Brazil. Malar J. 2019;18:18. [CrossRef] [PubMed] [Google Scholar]

[12] Brasil LW. Soares FR. Santoro AB. et al.: CYP2D6 activity and risk of recurrence of P. vivax malaria in Brazilian Amazon: a prospective cohort study. Malar J. 2018;17:57. [CrossRef] [PubMed] [Google Scholar]